Complement activation by substituted polyacrylamide hydrogels for embolisation and implantation

Biomaterials

Volumn 23, Issue 11, 2002, Pages 2319-2327

  Labarre, Denis ^a   Laurent, Alexandre ^b   Lautier, André ^a   Bouhni, Safia ^a   Kerbellec, Laurent ^a   Lewest, Jean Marc ^a   Tersinet, Nicolas ^a  

^a UNIV PARIS SUD   (France)

^b HÔPITAL LARIBOISIÈRE   (France)

Author keywords

Complement activation; Embolisation; Hydrogels; Hydroxylated polymer surfaces; Microspheres; Porosity; Roughness; Substituted polyacrylamides; Sulphonate

Indexed keywords

CROSSLINKING; HYDROGELS; IMPLANTS (SURGICAL); POLYMERIZATION; POLYSTYRENES; SULFUR COMPOUNDS;

INFLAMMATORY REACTION;

BIOMATERIALS;

EMBOSPHERE; MICROSPHERE; POLYACRYLAMIDE; POLYMER; POLY[N TRIS(HYDROXYMETHYL)METHYLACRYLAMIDE]; SEPHADEX; TRISACRYL; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; DERIVATIZATION; DRUG MANUFACTURE; HUMAN; HUMAN TISSUE; HYDROGEL; IN VITRO STUDY; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; STRUCTURE ACTIVITY RELATION;

EID: 0036129858     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0142-9612(01)00366-0     Document Type: Article

References (30)

1. Hydrogels in endovascular embolization I. Spherical particles of poly(2-hydroxyethyl methacrylate), their medico-biological properties
2. Hydrogels in endovascular embolization II. Clinical use of spherical particles
3. Suspension polymerization of 2-hydroxyethyl methacrylate in the presence of polymeric diluents; a novel route to spherical, highly porous beads for biomedical applications
4. Preparation of hydrogel beads from cross-linked poly(methyl methacrylate) microspheres by alkaline hydrolysis
5. Hydrogel microspheres from crosslinked poly(methyl methacrylate) (Hydrogel); a new material for interventional neuroradiology
6. Endovascular embolization using hydrogel microspheres
7. Microspheres for endovascular embolization
8. Trisacryl gelatin microspheres for therapeutic embolization I; development and in vitro evaluation
9. Trisacryl gelatin microspheres for therapeutic embolization II; preliminary clinical evaluation in tumors and arteriovenous malformations
10. Hemodialysis leukopenia; pulmonary vascular leukostasis resulting from complement activation by dialyser cellophane membranes
11. Complement activation during hemodialysis; clinical observations proposed mechanisms and theoretical implications
12. Complement activation by hydroxyethylmethacrylate-ethylmethacrylate copolymers
13. The ability of Sephadex to activate human complement is suppressed in specifically substituted functional Sephadex derivatives
14. Interactions of functionalized polystyrene derivatives with the complement system in human serum
15. Regulation of the human alternative complement pathway; formation of a ternary complex between factor H, surface-bound c3b and chemical groups on non-activating surfaces
16. Complement activation and adsorption of protein fragments in human serum, by functionalized polymer surfaces
17. Regulation by sulphonate groups of complement activation induced by hydroxymethyl groups on polystyrene surfaces
18. Specific interactions of polystyrene biomaterials with factor D of human complement
19. Activation of the complement system by polysaccharidic surfaces bearing carboxymethyl, carboxymethyl-benzylamide and carboxymethylbenzylamide sulphonate groups
20. Relationship between reduction of complement activation by polysaccharidic surfaces bearing diethylaminoethyl groups and their degree of substitution
21. Effect of PEO surface density on long-circulating PLA-PEO nanoparticles which are very low complement activators
22. Quantitative estimation of proteins by electrophoresis in agarose gels containing antibodies
23. Dialyser membranes; effect of surface area and chemical modification of cellulose on complement and platelet activation
24. Specific antibodies enhance Sephadex-induced activation of the alternative complement pathway in human serum
25. Conformational epitopes of C3 reflecting its mode of binding to an artificial polymer surface
26. Interactions of nanoparticles bearing heparin or dextran covalently bound to poly(methyl methacrylate) with the complement system